COMPASS PATHWAYS PLC Lease, Cost
COMPASS PATHWAYS PLC (CMPS) reported Lease, Cost of $2.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-24
- COMPASS PATHWAYS PLC lease, cost for the quarter ending 2024-03-31 was $638.00K, a 3.33% decline year-over-year.
- COMPASS PATHWAYS PLC lease, cost for the quarter ending 2023-12-31 was $658.00K, a 4.64% decline year-over-year.
- COMPASS PATHWAYS PLC lease, cost for the quarter ending 2023-09-30 was $653.00K, a 10.30% increase year-over-year.
- COMPASS PATHWAYS PLC lease, cost for the quarter ending 2023-06-30 was $639.00K, a 8.12% increase year-over-year.
- COMPASS PATHWAYS PLC lease, cost for fiscal 2025 was $2.41M, a 6.30% decline from fiscal 2024.
- COMPASS PATHWAYS PLC lease, cost for fiscal 2024 was $2.57M, a 1.53% decline from fiscal 2023.
- COMPASS PATHWAYS PLC lease, cost for fiscal 2023 was $2.61M, a 3.61% increase from fiscal 2022.
- COMPASS PATHWAYS PLC lease, cost for fiscal 2022 was $2.52M, a 30.52% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.41M 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $2.57M 10-K · filed 2026-03-24 | |||
| 2024-03-31 | $638.00K 10-Q · filed 2024-05-08 | $1.30M derived: sum of 2 quarters · filed 2025-02-27 | $1.95M derived: sum of 3 quarters · filed 2025-02-27 | $2.59M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $658.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.31M derived: sum of 2 quarters · filed 2025-02-27 | $1.95M derived: sum of 3 quarters · filed 2025-02-27 | $2.61M 10-K · filed 2025-02-27 |
| 2023-09-30 | $653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.29M derived: sum of 2 quarters · filed 2023-11-02 | $1.95M 10-Q · filed 2023-11-02 | $2.64M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | $639.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.30M 10-Q · filed 2023-08-03 | $1.99M derived: sum of 3 quarters · filed 2024-05-08 | $2.58M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $660.00K 10-Q · filed 2024-05-08 | $1.35M derived: sum of 2 quarters · filed 2024-05-08 | $1.94M derived: sum of 3 quarters · filed 2024-05-08 | $2.53M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $690.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.28M derived: sum of 2 quarters · filed 2024-02-29 | $1.87M derived: sum of 3 quarters · filed 2024-02-29 | $2.52M 10-K · filed 2024-02-29 |
| 2022-09-30 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.18M derived: sum of 2 quarters · filed 2023-11-02 | $1.83M 10-Q · filed 2023-11-02 | $2.69M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $591.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.24M 10-Q · filed 2023-08-03 | $2.10M derived: sum of 3 quarters · filed 2024-02-29 | $2.58M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $646.00K 10-Q · filed 2023-05-11 | $1.51M derived: sum of 2 quarters · filed 2024-02-29 | $1.99M derived: sum of 3 quarters · filed 2024-02-29 | $2.27M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.35M derived: sum of 2 quarters · filed 2024-02-29 | $1.62M derived: sum of 3 quarters · filed 2024-02-29 | $1.93M 10-K · filed 2024-02-29 |
| 2021-09-30 | $482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $754.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.06M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $582.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $310.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $1.00M 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $400.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |